US Physical Therapy Inc USPH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
U.S. Physical Therapy Presented at the BofA Securities 2026 Healthcare Conference
-
U.S. Physical Therapy Reports Record First Quarter Revenue, Reaffirms Full Year Guidance
-
U.S. Physical Therapy, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call Dates
-
U.S. Physical Therapy Announces $450 Million Credit Facility
Trading Information
- Previous Close Price
- $62.84
- Day Range
- $63.36–63.50
- 52-Week Range
- $58.19–93.50
- Bid/Ask
- $62.18 / $64.46
- Shares Outstanding
- 15.22M
- Market Cap
- $966.39M
- Volume/Avg
- 17,812 / 199,266
Key Statistics
- Price/Earnings (Normalized)
- 25.20
- Price/Sales
- 1.25
- Dividend Yield (Trailing)
- 2.90%
- Dividend Yield (Forward)
- 2.90%
- Total Yield
- 3.33%
Company Profile
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Core
- Total Number of Employees
- 7,294
- Website
- https://www.usph.com
Valuation
|
Metric
|
USPH
|
|---|---|
Price/Earnings (Normalized) | 25.20 |
Price/Book Value | 2.13 |
Price/Sales | 1.25 |
Price/Cash Flow | 9.77 |
Price/Earnings
USPH
Financial Strength
|
Metric
|
USPH
|
|---|---|
Quick Ratio | 1.07 |
Current Ratio | 1.19 |
Interest Coverage | 8.12 |
Quick Ratio
USPH
Profitability
|
Metric
|
USPH
|
|---|---|
Return on Assets (Normalized) | 3.30% |
Return on Equity (Normalized) | 8.09% |
Return on Invested Capital (Normalized) | 4.30% |
Return on Assets
USPH
Medical Care Facilities Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| HCA Healthcare Inc
HCA
| Zbnchch | Kbpkxw | $86B | |||
| Fresenius SE & Co KGaA ADR
FSNUY
| — | Ycvkb | $26B | |||
| IHH Healthcare Bhd
IHHHF
| — | Cdnmn | $19B | |||
| Tenet Healthcare Corp
THC
| Cjyxlxxyd | Dkvhpkv | $15B | |||
| DaVita Inc
DVA
| Xgkzwdwy | Fvncph | $14B | |||
| Fresenius Medical Care AG ADR
FMS
| Cppljsq | Typcnd | $13B | |||
| Fresenius Medical Care AG
FMCQF
| — | Ytkbm | $13B | |||
| Encompass Health Corp
EHC
| — | Sqkfrzd | $10B | |||
| Ensign Group Inc
ENSG
| — | Xxccls | $9B | |||
| Genesis Healthcare Inc Class A
GENNQ
| Srjk | Yhjj | $12,220 |
United States